Showing: 1 - 2 of 2 RESULTS

Michigan Medicine begins recruitment for phase 3 of Janssen COVID-19 vaccine trial

ANN ARBOR, Mich. (WXYZ) — The University of Michigan announced Monday that Michigan Medicine has begun recruiting for phase 3 of the Janssen COVID-19 clinical trial.

The trial, known as the ENSEMBLE study, will evaluate a vaccine for the prevention of COVID-19 as part of a double-blind phase 3 clinical trial.

U-M is one of several sites across the world supporting the trial, which hopes to enroll up to 60,000 people worldwide.

“Michigan Medicine is committed to supporting the continued study of the investigational Janssen vaccine and other vaccine candidates. These trials are crucial to moving us toward an effective vaccine,” says Marschall Runge, M.D., Ph.D., Dean, U-M Medical School, Executive Vice President, Medical Affairs and CEO, Michigan Medicine.

This is the second trial being done on COVID-19 vaccines at U-M. They are also doing an AstraZeneca trial.

Enrollment is open for both trials now, and you can apply to be part of it by visiting uofmhealth.org/covid19-vaccine

appId : '390778121043807',

xfbml : true, version : 'v2.9' }); }; (function(d, s, id){ var js, fjs = d.getElementsByTagName(s)[0]; if (d.getElementById(id)) {return;} js = d.createElement(s); js.id = id; js.src = "https://connect.facebook.net/en_US/sdk.js"; fjs.parentNode.insertBefore(js, fjs); }(document, 'script', 'facebook-jssdk'));

Source Article

Michigan Medicine, Janssen now recruiting for phase 3 COVID-19 vaccine trial

ANN ARBOR – Michigan Medicine and Janssen, a division of Johnson & Johnson, are now recruiting for a double-blind phase III COVID-19 vaccine clinical trial.

Known as the ENSEMBLE study, the trial will test an investigational vaccine to prevent COVID-19.

The University of Michigan is one of several test sites around the globe supporting the trial, which aims to enroll up to 60,000 volunteers. Researchers hope to enlist a diverse group of participants in the latest trial as part of Operation Warp Speed, a U.S. Department of Health and Human Services public/private partnership.

  Like what you’re reading? Sign up for our email newsletter here!

“Michigan Medicine is committed to supporting the continued study of the investigational Janssen vaccine and other vaccine candidates. These trials are crucial to moving us toward an effective vaccine,” Marschall Runge, M.D., Ph.D., Dean, U-M Medical School, Executive Vice President, Medical Affairs and CEO, Michigan Medicine said in a statement.

The Janssen study is the second COVID-19 trial to be recruiting at U-M, along with the AstraZeneca trial. Once enrollment opens for the trials, interested participants who meet qualifying criteria will be considered.

For more information about the study, visit https://www.uofmhealth.org/covid19-vaccine or email JanssenVaccineStudy@med.umich.edu.

Copyright 2020 by WDIV ClickOnDetroit – All rights reserved.

Source Article